{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T19:05:18Z","timestamp":1789239918415,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,27]],"date-time":"2027-04-27T00:00:00Z","timestamp":1808784000000},"content-version":"am","delay-in-days":422,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23DA042326"],"award-info":[{"award-number":["K23DA042326"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Academy of Consultation-Liaison Psychiatry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jaclp.2025.11.001","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T12:23:54Z","timestamp":1768393434000},"page":"94-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transdermal Initiation of Buprenorphine Among Hospitalized Persons: A Retrospective Study"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7271-0018","authenticated-orcid":false,"given":"David B.","family":"Hathaway","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7215-1778","authenticated-orcid":false,"given":"Veronica","family":"Szpak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Prostko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Vercollone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasra Ali","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8255-8387","authenticated-orcid":false,"given":"Alysse","family":"Wurcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5659-6147","authenticated-orcid":false,"given":"Joji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaclp.2025.11.001_bib1","series-title":"Social Determinants of Health and County Population Rates of Opioid-Related Inpatient Stays and Emergency Department Visits, 2016","author":"Owens","year":"2020"},{"key":"10.1016\/j.jaclp.2025.11.001_bib2","article-title":"National U.S. time-trends in opioid use disorder hospitalizations and associated healthcare utilization and mortality","volume":"15","author":"Singh","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jaclp.2025.11.001_bib3","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1111\/bcp.14857","article-title":"Pattern and burden of opioid-related hospitalizations in the USA from 2016 to 2018","volume":"87","author":"Bedi","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaclp.2025.11.001_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003759","article-title":"Fatal opioid overdoses during and shortly after hospital admissions in England: a case-crossover study","volume":"18","author":"Lewer","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.jaclp.2025.11.001_bib5","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1176\/appi.ajp.23180008","article-title":"Treatment of opioid use disorder in the general hospital","volume":"180","author":"Funk","year":"2023","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaclp.2025.11.001_bib6","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.annemergmed.2022.05.032","article-title":"A neuropharmacological model to explain buprenorphine induction challenges","volume":"80","author":"Greenwald","year":"2022","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jaclp.2025.11.001_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2023.1982","article-title":"Characteristics and prescribing patterns of Clinicians waivered to prescribe buprenorphine for opioid use disorder before and after release of new practice guidelines","volume":"4","author":"Jones","year":"2023","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.jaclp.2025.11.001_bib8","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.2147\/JMDH.S449748","article-title":"Frontline perspectives on buprenorphine for the management of chronic pain","volume":"17","author":"Adler","year":"2024","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.jaclp.2025.11.001_bib9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJMra1604339","article-title":"Treatment of opioid-use disorders","volume":"375","author":"Schuckit","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaclp.2025.11.001_bib10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/ADM.0000000000001202","article-title":"ASAM clinical considerations: buprenorphine treatment of opioid use disorder for individuals using high-potency synthetic opioids","volume":"17","author":"Weimer","year":"2023","journal-title":"J Addict Med"},{"key":"10.1016\/j.jaclp.2025.11.001_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/add.16646","article-title":"Incidence of buprenorphine-precipitated opioid withdrawal in adults with opioid use disorder: a systematic review","volume":"120","author":"Gregory","year":"2025","journal-title":"Addiction"},{"key":"10.1016\/j.jaclp.2025.11.001_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108147","article-title":"Protracted renal clearance of fentanyl in persons with opioid use disorder","volume":"214","author":"Huhn","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jaclp.2025.11.001_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13722-025-00548-z","article-title":"Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: an updated systematic review","volume":"20","author":"Adams","year":"2025","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.jaclp.2025.11.001_bib14","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1521-0391.2011.00159.x","article-title":"Transdermal buprenorphine to switch patients from higher dose methadone to buprenorphine without severe withdrawal symptoms: transdermal buprenorphine for treatment of opiate withdrawal","volume":"20","author":"Hess","year":"2011","journal-title":"Am J Addict"},{"key":"10.1016\/j.jaclp.2025.11.001_bib15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/ajad.13135","article-title":"Microinduction of buprenorphine\/naloxone: a review of the literature","volume":"30","author":"Ahmed","year":"2021","journal-title":"Am J Addict"},{"key":"10.1016\/j.jaclp.2025.11.001_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/ADM.0000000000001163","article-title":"Survey of buprenorphine low-dose regimens used by healthcare institutions","volume":"17","author":"Hardy","year":"2023","journal-title":"J Addict Med"},{"key":"10.1016\/j.jaclp.2025.11.001_bib17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jamainternmed.2018.6749","article-title":"Initiating opioid agonist treatment for opioid use disorder in the inpatient setting: a teachable moment","volume":"179","author":"Raheemullah","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaclp.2025.11.001_bib19","series-title":"Pain Management Tables and Guidelines","author":"Kematick","year":"2024"},{"key":"10.1016\/j.jaclp.2025.11.001_bib20","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/ADM.0000000000001146","article-title":"Low-dose initiation of buprenorphine in hospitalized patients using buccal buprenorphine: a case series","volume":"17","author":"Adams","year":"2023","journal-title":"J Addict Med"},{"key":"10.1016\/j.jaclp.2025.11.001_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/ADM.0000000000001236","article-title":"Evaluation of low-dose buprenorphine initiation with buprenorphine buccal films in hospitalized patients: a retrospective cohort study","volume":"18","author":"Arnouk","year":"2024","journal-title":"J Addict Med"},{"key":"10.1016\/j.jaclp.2025.11.001_bib22","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1080\/15563650.2022.2028802","article-title":"Transdermal buprenorphine for in-hospital transition from full agonist opioids to sublingual buprenorphine: a retrospective observational cohort study","volume":"60","author":"Baumgartner","year":"2022","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.jaclp.2025.11.001_bib23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/ADM.0000000000000947","article-title":"Low dose buprenorphine induction with full agonist overlap in hospitalized patients with opioid use disorder: a retrospective cohort study","volume":"16","author":"Bhatraju","year":"2022","journal-title":"J Addict Med"},{"key":"10.1016\/j.jaclp.2025.11.001_bib24","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1097\/ADM.0000000000000864","article-title":"Low-dose buprenorphine initiation in hospitalized adults with opioid use disorder: a retrospective cohort analysis","volume":"16","author":"Button","year":"2022","journal-title":"J Addict Med"},{"key":"10.1016\/j.jaclp.2025.11.001_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11916-023-01116-3","article-title":"Low-dose initiation of buprenorphine: a narrative review","volume":"27","author":"Edinoff","year":"2023","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.jaclp.2025.11.001_bib26","article-title":"Low-dose buprenorphine initiation and treatment continuation among hospitalized patients with opioid dependence: a retrospective cohort study","volume":"158","author":"Hayes","year":"2024","journal-title":"J Subst Use Addict Treat"},{"key":"10.1016\/j.jaclp.2025.11.001_bib27","doi-asserted-by":"crossref","first-page":"e1872","DOI":"10.1093\/milmed\/usaa068","article-title":"Case report: buprenorphine induction using transdermal buprenorphine in a veteran with opioid use disorder and psychosis, managing precipitated withdrawal","volume":"185","author":"Kinasz","year":"2020","journal-title":"Mil Med"}],"container-title":["Journal of the Academy of Consultation-Liaison Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667296025008985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667296025008985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:46:15Z","timestamp":1777311975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667296025008985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2667296025008985"],"URL":"https:\/\/doi.org\/10.1016\/j.jaclp.2025.11.001","relation":{},"ISSN":["2667-2960"],"issn-type":[{"value":"2667-2960","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transdermal Initiation of Buprenorphine Among Hospitalized Persons: A Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Academy of Consultation-Liaison Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaclp.2025.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}